Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP7035 for nocturia associated with nocturnal polyuria
2013-003701-25Phase 2Completed
- Sponsor
- Tacurion Pharma
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nocturnal polyuria (NP) comparing ASP7035 forced titration with Placebo (2 arms). Primary endpoint: Change in mean number of nocturnal voids from baseline to the last hyponatremia-free dose. Started Oct 2013; status: completed.
02
Drugs
ASP7035
03
Conditions
nocturnal polyuria (NP)
Beyond the preview
Go deeper on 2013-003701-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003701-25.